학술논문
Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma
Document Type
Article
Author
Source
In: Clinical Hematology International . (Clinical Hematology International, March 2023, 5(1):43-51)
Subject
Language
English
ISSN
25900048